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AbsTrACT
This article examines how people who are shorter 
than average make sense of their lived experience of 
embodiment. It offers a sociophenomenological analysis 
of 10 semistructured interviews conducted in the 
Netherlands, focusing on if, how, and why height matters 
to them. It draws theoretically on phenomenological 
discussions of lived and objective space, intercorporeality 
and norms about bodies. The analysis shows that height 
as a lived phenomenon (1) is active engagement in 
space, (2) coshapes habituated ways of behaving and 
(3) is shaped by gendered norms and beliefs about 
height. Based on this analysis, the article challenges 
what we label as the ’problem-oriented approach’ 
to discussions about growth hormone treatment for 
children with idiopathic short stature. In this approach, 
possible psychosocial disadvantages or problems of 
short stature and quantifiable height become central 
to the ethical evaluation of growth hormone treatment 
at the expense of first-hand lived experiences of short 
stature and height as a lived phenomenon. Based on 
our sociophenomenological analysis, this paper argues 
that the rationale for giving growth hormone treatment 
should combine medical and psychological assessments 
with investigations of lived experiences of the child. Such 
an approach would allow considerations not only of 
possible risks or disadvantages of short stature but also 
of the actual ways in which the child makes sense of her 
or his height.
TreATing shorT Children wiTh growTh 
hormone
Short stature has been described as ‘one of the most 
common concerns presenting to pediatric endocri-
nologists and other physicians caring for children’ 
(Cohen, p. 4211).1 This is the case, others have 
added, because short stature might be an indi-
cator of certain diseases such as Turner syndrome 
or Prader-Willi syndrome and also because it is 
commonly regarded as an undesirable bodily mark.2 
In medical terms, children who are short for other 
than identified medical reasons fall into the cate-
gory of idiopathic short stature (ISS). This is a 
statistical definition only possible by exclusion of 
all known medical reasons for short stature (such 
as small for gestational age or chronic renal insuf-
ficiency).3 Some countries, such as the USA, allow 
the use of human growth hormone treatment (here-
after referred to as hGH) to increase the height of 
children with ISS. However, debates are ongoing as 
regards ethical aspects of offering or not offering 
such treatment. HGH has been defined as cosmetic 
endocrinology,4 enhancement5 or pharmaceuticali-
sation.6 The debate on the rationale for hGH treat-
ment touches on different argumentsi and has largely 
moved beyond the entanglement of aesthetics and 
health,7 focusing rather on the relevance of psycho-
social disadvantage and stigma or possible practical 
limitations in everyday life8 or even possible phys-
ical and/or psychosocial disability.9 The Pediatric 
Endocrine Society recently stated that ISS is still a 
‘controversial indication’ and stresses the need for 
further studies on the relevance of height for chil-
dren and adults (Grimberg, p. 362).9 
The aim of this article is to show how and 
why attendance to lived experiences of height is 
needed in bioethical and biomedical discussions of 
hGH treatment for children with ISS. The article 
proceeds in three steps. First, we describe the ‘prob-
lem-oriented approach’ to the debate on hGH 
treatment for children with ISS. In this approach, 
possible psychosocial disadvantages or problems of 
short stature become central to discussions about 
hGH treatment at the expense of first-hand lived 
experiences of short stature. This approach also 
centres more on objective and quantifiable meas-
ures than on height as a lived phenomenon. Second, 
we offer a sociophenomenological analysis of 
whether and, if so, when, and how height matters 
for interviewed adults in the Netherlands who are 
shorter than average without any known medical 
reasons for their short stature. Third, we show how 
our sociophenomenological analysis of the inter-
views contributes to biomedical and bioethical 
discussions on using hGH treatment for children 
with ISS. Based on the sociophenomenological 
analysis, we critically engage with the problem-ori-
ented approach, through the short-stature-specific 
quality of life tool called QoLISSY. We understand 
QoLISSY as an example of a tool that harmonises 
with the problem-based approach and explain why 
this is problematic.
The problem-orienTed ApproACh
Since the 1930s, various attempts have been 
made to increase height, including, for example, 
anabolic steroids, leg lengthening surgery and 
cadaveric growth hormone.6 In 1985, recombinant 
i Besides disagreements on the rationale of hGH 
treatment, other ethical issues of giving hGH treat-
ment to children with ISS concern cost-effective-
ness and uncertainties about both long-term safety 
and increase in quality of life of treated children.
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hGH was produced in laboratory, overcoming previous tech-
nical problems and allowing improved safety and larger drug 
supply. Since then, hGH treatment has been used worldwide as 
a replacement therapy for children with growth hormone defi-
ciency (GHD)ii or as a therapy to gain metabolic benefits as in 
the case of Turner syndrome,2 but in some countries (such as the 
USA), it has also been used to increase the height of children 
with ISS.6iii HGH treatment is currently prescribed in the Neth-
erlands for six medical conditions.iv Even though hGH treat-
ment has not received regulatory approval in Europe for general 
administration to children with ISS, it is available via ‘off label’ 
prescriptions.v
ISS is the term used to identify children whose height is below 
−2 SDs for a given age, sex and population group.3 Although 
various clinical studies and evaluations have been made to assess 
the risks and benefits of hGH treatment for children with ISS, 
uncertainties remain about the long-term side effects.1 10 11 
Therefore, recombinant hGH has not been granted marketing 
authorisation in Europe for the indication of ISS.12 Recently, 
in the USA, the Pediatric Endocrine Society has recommended 
some restrictions on its use.9 Concerns have arisen regarding the 
long-term safety and about the rationale of the treatment.
The category of ISS has received particular attention in the 
biomedical and bioethical debates on using hGH treatment for 
two main reasons. First, unlike children with other conditions 
treated with hGH, children with ISS do not have any known 
medical conditions that result in short stature. While categories 
such as Turner syndrome and Prader-Willi syndrome are recog-
nised diseases for which short stature is one of the symptoms, this 
is not the case for ISS.6 Second, there is considerable disagree-
ment around the status of ISS. Some scholars see it as a category 
that describes children as shorter than the average yet as part 
of the continuum of healthy bodily variations. Gill 2006, for 
instance, defines children with ISS as small normal children.13 
Others understand ISS as aligned with the notion of idiopathic 
conditions, considering them to be disorders for which no cause 
is currently known but for which one is anticipated to exist.14
The main reason given in biomedical and bioethical literature 
for increasing the height of children with ISS is that short stature 
might cause psychological and social problems,1 15 based on the 
idea that short stature is a burden that carries social stigma and 
disadvantage.16 17 The perception of short stature as something 
primarily negative, including prejudice against short individuals, 
is commonly referred to as heightism.18 Some studies do indicate 
associations between short stature and different social aspects, 
in particular for men, such as lower social status (in France19 
and in the Philippines),20 lower chances of getting married (in 
Italy)21 or greater risk for psychosis or suicide (in Sweden).22 
Nonetheless, no proven relation exists between behavioural, 
ii GHD is diagnosed when the pituitary gland, the gland in charge 
of secreting growth hormone (GH), does not produce enough 
GH to allow the correct development of the child.
iii It is worthwhile to mention that it exists also an oestrogen 
treatment to reduce tall girls’ height. See, e.g., the articles: Lee 
and Howell (2006), 66 or Rayner et al (2010).67
iv Pediatric conditions currently approved for hGH in the Neth-
erlands are GHD, chronic renal insufficiency, Turner syndrome, 
Prader-Willi syndrome, small for gestational age and growth 
failure after a stem cell transplantation (http://kindengroei.nl/
behandeling/indicatiestelling-vergoeding/).
v Schönbeck et al (2013) write that ‘the Dutch referral criteria 
require children with a height SDS of less than −3 SD to be 
referred for short stature’ (Schönbeck, p. 371).55
psychological and social problems and short stature16 23 24 nor is 
there any evidence that hGH treatment might improve psycho-
logical functioning.25 26
Several studies in psychology and quality of life literature have 
also focused on whether or not children with ISS are at greater 
risk of psychosocial problems. Some studies claim that short 
stature is related to an increase in developmental, social and 
educational problems.27 Others argue that since short people are 
perceived as less competent, they are more likely to be disadvan-
taged in the workplace and have lower positions.28 However, 
many studies that show psychological problems have been criti-
cised for their methodological limitations, lacking, for instance, 
a control group of average height children29 or including only 
those children who were referred to the endocrinology clinic (as 
opposed to those who never consulted doctors because of their 
height).16 Some other studies, instead, show that children with 
ISS show no relevant difference from children of average height 
in terms of psychosocial problems.24 Moreover, while some 
studies focus on the group/population level,30 others recom-
mend looking primarily at individual variations.31
In this paper, we label the discussions about hGH based on the 
idea that short stature might be a psychosocial problem as ‘the 
problem-oriented approach’. This approach argues that hGH 
treatment aims primarily at the ‘prevention and treatment of 
potential risks for psychosocial development’ (Noeker, p. 81)3 
and considers short stature to be the ‘primary outward trigger 
of stress’ (Noeker, p. 80).3 While there are some variations to 
this approach—for example, some claim the main sources of 
psychosocial burdens are the negative stereotypes regarding 
short stature rather than height itself15 32—the problem-oriented 
approach arrives at the conclusion that hGH treatment is recom-
mended because height increase might prevent risks of future 
presumed or potential disadvantage or increase quality of life of 
children with ISS.1 3 9 15 32 Further, what we label as the prob-
lem-oriented approach deems objective and quantifiable height 
as central to discussions on growth hormone treatment in the 
sense that it sees height as the cause and solution to potential 
problems for children with ISS later in life.
A soCiophenomenology of The body
Against this background, this study offers a sociophenomenolog-
ical analysis of the lived experiences of short stature that draws 
on phenomenology of embodiment.
phenomenology of embodiment
Phenomenology of the embodied self as being-in-the-world 
offers detailed explorations of the role of the body for subjec-
tivity, including how lived embodied experiences of illness, pain 
or impairment can affect a person’s bodily self-awareness, body 
image and agency.33–37 It also explores lived experience of the 
body, with a particular sex, of a particular age, race and ability. 
38–40 It explores how medical interventions modify bodies and 
what such modifications mean for subjectivity  and agency, for 
example, in relation to intersex conditions,41 42 breast recon-
structions after cancer43 or disfigurement.44
Phenomenological reasoning starts from the understanding of 
subjectivity as embodied and situated in the world and in rela-
tion to others, where our basic mode of being is pre-reflective 
and practical, and where any ‘independent agency is intrinsically 
dependent on the situation in which it is articulated’ (Käll and 
Zeiler, p. 101).45 The embodied self is understood as never just 
consciousness, nor just a thing, but always both in an ambig-
uous relation to each other. As put in a formulation that seeks 
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to capture what phenomenologists commonly refer to as the 
bodily ambiguity of the lived body: ‘I am the body that I have’ 
(Slatman, p. 168).46 In this reasoning, the lived body is and sets 
the conditions of possibility of perception and action, and the 
body that someone is, is also what this person can experience as 
thing-like.
Furthermore, our bodily mode of being-in-the-world is consti-
tuted of ‘the context of meaningful relations with which we are 
involved’ (Diprose, p. 241, 239).47 The notion of the lived body, 
then, refers to the ‘intertwining’ of body and world (Merleau-
Ponty, p. 138).48 The lived body is a lived relation to a (material 
and social) world immersed in meaning. It is the site of self-be-
coming ‘in which the interface with others—both objects and 
living beings—constructs a dynamic self in which abstract singu-
larity plays no part’ (Shildrick, p. 110).49
This study explores the experience of being shorter than 
average, focusing primarily on the intertwining of the lived and 
the objective space, intercorporeality in relation to others and 
things and lived norms understood as follows.
First, the phenomenological focus on lived experiences of 
height allows for distinguishing between objective space—
that is, the physical, geometrical, conceptual space—and subjec-
tive space—that is, the lived, phenomenal, practical space which 
can be experienced differently, for instance, with changes in our 
moods or our bodily abilities.37 50 Lived space emerges from 
the relationship to our environment that is both produced and 
perceived, in continuous construction and with variable rela-
tions with objective space. According to Merleau-Ponty, one 
would not say that one’s arm ‘is beside the ash-tray in the way 
in which the ash-tray is beside the telephone’ (Merleau-Ponty, 
p. 98).48 The spatiality of the body ‘is not, like that of external 
objects or like that of ‘spatial sensations’, a spatiality of position, 
but [it is] a spatiality of situation’ (Merleau-Ponty, p. 100).48 This 
formulation stresses the spatial and temporal unity of the body 
being involved in its tasks. The body is not merely ‘in space, 
in time’ but ‘inhabits space and time’ (Merleau-Ponty, p. 139).48 
The embodied subject’s inhabiting space is a matter of time 
and movement. It is about our ‘moving in relation to things,’ 
which is ‘independent from the abstract conception of space’ 
(Morris, p. 115).51
Second, the embodied self inhabits a social world, and the 
embodied self as being-in-the-world is always being-with 
others. This idea is already part of the reasoning on the lived 
body as a site of self-becoming, constituted by dynamic rela-
tions with others, things and the world. Scholars have used the 
notion of intercorporeality to emphasise the non-discreteness 
and basic openness of bodies, and the relational becoming of 
bodily selves (where singular, that is, unique and different, lived 
bodies are continuously shaped and come to be in exchanges 
between bodies).45 52–54 In this article, we use the concept of 
intercorporeality to refer to the ways embodied subjectivity 
and agency is shaped dynamically in relations with others and 
things.
Third, phenomenology has examined how norms and beliefs 
about specific bodies can become incorporated—through 
being repeatedly enacted and expressed—into someone’s lived 
body.41 42 Such work has examined how bodily expressed or 
enacted assumptions and norms that are deeply engrained in our 
habitual bodily existence, experienced ‘as of-a-piece’ with our 
existence, can help shape the things we simply do and intuitively 
feel that we should do (Zeiler, p. 82).41 Incorporating assump-
tions and norms into someone’s lived body can enable seamless 
interaction as long as others have incorporated similar assump-
tions and norms through a tacitly shared bodily know-how.
methodology
Our analysis builds on interviews conducted in the Netherlands 
in 2016 with 10 people between 18 and 52 years old who are 
shorter than average. The Netherlands has the tallest population 
of any country in the world, with an average height of 183.8 cm 
for men and 170.7 cm for women.55 We interviewed six women 
ranging from 150 cm to 159 cm and four men between 166 cm 
and 169 cm.vi The first author used three main recruitment 
methods: she sent out information about the research via Dutch 
associations for little people, via information flyers (in person 
and through social networks) and used snowball sampling. Only 
one participant was recruited through an association.
Staying attuned to interviewees’ lived experiences of height 
as narrated from a first-person perspective, we pursued what 
one of us has labelled a ‘sociophenomenology of the body’ 
(Slatman, p. 555),34 and attended to the interviewees’ narrated 
experiences, paying attention to sociocultural dimensions. We 
also attended to material dimension of bodily existence and 
coexistence.56 The interviews focused on participants’ narrations 
of their everyday experiences of height, including narrations of 
situations in which they came to think about or note their height. 
At the end of the interviews, participants were also asked about 
their experiences with and/or knowledge of hGH treatment.
Only two participants did not know of any medical interven-
tions for short stature before the interviews, while the others had 
heard about hGH treatment. Four had more direct experiences: 
three when they were children and were informed by the doctors 
that hGH treatment might have been an option for them and one 
when hGH for was proposed for his daughters. They all refused 
hGH treatment, and no one had direct experience with it.
Interviews lasted on average 1 hour. They were digitally 
recorded and then transcribed verbatim. The first author 
conducted and transcribed all the interviews, while the three 
authors read the transcripts line-by-line and interpreted the data. 
In the analysis phase, the collected data were interpreted by using 
the phenomenological hermeneutical method.57vii Applying this 
approach to the collected data, the authors first attributed open, 
descriptive codes to excerpts of the interviews that were related 
to participants’ experiences and reflections on height. Exam-
ples of these codes include figurative height, being used to it, 
others’ behaviour, comparison with tall/short people, look up/
down, gender discourse. Second, on the basis of these codes, the 
authors identified three general themes, and engaged with these 
themes via the conceptual framework of sociophenomenology 
of embodiment. The three identified themes are (1) height is 
narrated as active engagement in space, in and through relations 
with others, (2) height coshapes habituated ‘I can’ through inter-
corporeal exchanges with others and things and (3) the meaning 
of height is framed by incorporated gendered norms and beliefs.
 Ethical considerations were addressed in all phases of the 
research process. All participants provided written informed 
vi All pathological conditions, such as achondroplasia or GHD, 
were excluded.
vii We use the phenomenological hermeneutical method to pursue 
our sociophenomenology of the body for two main reasons. It 
required us to explore participants’ lived experiences attending 
our taken-for-granted prejudices and assumptions on height 
through self-reflectivity. It also allowed us to engage in an 
interpretation of the empirical data that examines the situated 
and embodied experiences of participants, with a focus on the 
sociocultural and material aspects of embodied and situated 
coexistence.
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consent to the study. Transcribed interviews were anonymised, 
and all personal data were kept confidential and locked in a safe.
mAking sense of heighT
height as active engagement in space
This first theme addresses the ways participants narrate their own 
height in and through relations to others in their daily embodied 
engagement in space. Most of the interviewees define themselves 
as not ‘very short’, just on the edge of the study requirements. 
While Frank claims ‘I am quite short, but not too short’ [our 
italics], Jack acknowledges that he is shorter than the Dutch 
average but describes his height as ‘acceptable’. In all the inter-
views, objective and lived height seem to intertwine; they overlap 
and shape each other, with reference to a variety of images and 
qualitative representations. For instance, when Hannie mentions 
people that she considers short, she refers to them as ‘a head 
shorter’ than she is. She also claims that she needs to ‘stand up’ 
to say how much shorter they are. Hannie explains: ‘because I 
don’t know how tall I am… I don’t know, like this? [pointing at 
her shoulders]’.
Most of the participants explain that in everyday life, they 
only occasionally become aware of how tall they are. As put by 
Jack, he does not think about height unless he meets someone 
who is as tall as he is: ‘If I see someone who is maybe the same 
height as me or maybe smaller, then, then I really think “Wow, 
he’s small!” and then the next time I think “Shit, I’m the same 
height”. You know?’ Jack continues:
I do see, I do notice that other guys, especially guys, are small too. 
I think ‘Oh, this is a small guy’ but I’m the same height. So, that’s 
funny that you do see it, that another guy is smaller than the average 
Dutch guy and, and then…. Yeah. So, it’s noticeable also for me, that 
I’m the same height.
Other participants recount similar experiences of sometimes 
noting their own height in interactions with others. Some, such 
as Milly and David, explain that they become aware of their 
height primarily when others make remarks.
When participants talk about their own height, objective and 
quantifiable descriptions are mostly overshadowed by their 
accounts of how they live their height. Recounting a mundane 
situation, Milly says:
When I’m walking with my boyfriend, we’ve been together for 12 
years now, he is 183 [cm]. I don’t feel he is like really a lot taller. Only 
30 cm, that’s like this [indicating with her hands], so…
Besides the measurement in centimetres, Milly refers to her 
own body to define her boyfriend’s height. Even if she states 
that there are positive and negative aspects of being shorter 
than average, she has an overall positive narrative. She says that 
her boyfriend is attracted to her short stature, and that she is 
proud of being short. She says that she would not like to be 
taller, because if she were, she would lose something that makes 
her ‘unique’. Milly also comments that when she compares 
herself with others who are taller, she does not feel small. It is 
others who are ‘really’ tall. While she measures 20 cm below the 
average Dutch woman, her attention focuses on others’ tallness 
rather than her shortness.
When people are ‘really’ tall, Milly says that she feels ‘sorry’ 
or ‘pity’ for them because they might have problems in daily 
life. For instance, she says ‘sometimes that’s a problem for me 
as well [finding clothes of the right size], but when jeans are too 
long, I can make them short. When you are tall, they are just 
too short, you cannot make them longer’. Talking about sports, 
Milly adds that it is ‘unhealthy’ to be really tall as ‘everything is 
out of balance’. On a similar note, David comments that even 
if taller people might be stronger than he is in general terms, 
he is ‘relatively very strong’ because he is more ‘aerodynamic’ 
than they are, and he can easily support his own weight in 
gymnastics. David’s narrative also changes according to the 
perspective he takes on his height. He recounts that when he 
looks at a particular picture of himself standing next to other 
people, he wonders about what others might think. He says that 
he asks himself whether they would ‘think less’ of him looking 
at the same picture. Maybe they would see him as deserving 
less consideration, or they would consider him as less impor-
tant than others. This attention to his body as an object, as if 
he were looking at it from the outside, could be understood as 
revealing some of his insecurities and can be contrasted with his 
description of his everyday engagement with the world, where 
he talks about his height in more positive terms (as, for instance, 
in sports, as mentioned above).
These interviewees’ accounts and descriptions emphasise 
what is often referred to as the pre-reflective level of embodied 
experience, where one does not attend reflectively to one’s own 
body, and to how height sometimes becomes thematised (i.e., 
something the interviewees attend to) in and through relation-
ships with others. Such thematisation happens in participants’ 
everyday engagement with the world: they assign meaning to 
height when they do things, when they engage with others and 
move in space. To clarify this point, we suggest a neologism that 
transforms height into a verb rather than a noun: ‘heighting’. 
In formulating this concept, we draw on Kevin Aho’s58 parallel 
between Merleau-Ponty’s and Heidegger’s conceptions of spati-
ality. Aho refers to Heidegger’s idea of ‘bodying-forth’ (Leiben) 
of the body (Aho, p. 10)58 to highlight the similar phenomeno-
logical understanding of space in the two authors’ work. Both 
Merleau-Ponty and Heidegger understand space not merely as an 
external relationship with things, like a ‘container within which 
objects of experience reside’ (Aho, p. 10),58 but also ‘in terms 
of pre-objective, everyday involvement, in terms of the constant 
dialectical interplay between the ‘bodying-forth’ of the body and 
the things that it encounters’ (Aho, p. 2).58 Just as bodying-forth 
is used as a verb, ‘heighting’ can be used as a verb for the way it 
helps stress the active and dynamic engagement—height in the 
‘doing’—described by interviewees. Participants describe lived 
height by the way in which they inhabit it. Moreover, height is 
described as ‘spatiality of situation’ rather than ‘spatiality of posi-
tion’ (Merleau-Ponty, p. 100),48 which means that participants, 
as always already immersed in a sociocultural context, actively 
respond to an actual surrounding, and make sense of themselves 
and their height in relation to that surrounding. The notion of 
heighting is intended to conceptualise what was central to this 
theme: from the lived perspective of the interviewees, height was 
made meaningful through active engagement in space—through 
action and interaction.
height, others and things coshape habituated ‘i can’
In participants’ accounts and narratives, lived height acquires 
meaning in spatial engagement and in concrete corporeal 
exchanges. Some bodily interactions with others and objects 
are repeatedly described as carrying special meanings for inter-
viewees in terms of shaping how they behave. Among these 
interactions, the direction of one’s gaze and the ability to see 
carry particular significance. Participants often mention that 
they have to ‘look up’ at taller people while talking, or that at 
social events they ‘can’t see’ properly because there is someone 
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or something obstructing their view. Linda recalls that during a 
concert she could not see the show on stage because of the hair-
style of the person sitting in front of her. She still prefers to sit 
during concerts because when she stands, she says, she normally 
looks at people’s back. She attributes some of her choices and 
actions to her ‘limited gaze’, for instance when describing how 
she avoids crowded places because she cannot ‘breathe’ properly. 
This feeling even induces her panic attacks:
I didn’t want to go there [to a city festival] because, because if you 
are smaller, everyone is bigger than me and it’s crowded, and I can’t 
see anything. I have panic attacks, then. It started a couple of years 
ago for the first time. And that’s, I think that’s related to being small. 
Because if you are big and you can see above everybody it’s not scary, 
but if you are small and you can’t see anything it’s… it’s… it’s scary. 
So, that makes me panic.
Crowded places scare Linda, who attributes her visual limi-
tations to her height. Being the shortest person among taller 
people creates the feeling that crowded events are inhospitable 
situations that, she says, she prefers to avoid. Linda has an overall 
negative narration as she recounts that being short is sometimes 
difficult for her. She claims: ‘nobody likes to be short’, and she 
is the only participant who mentions that she felt she needed to 
join an association for short people, just to be with others ‘who 
are also small’. At first, it was strange to her because, she says, 'I 
was always used to look up at somebody and now I had to look 
down. So, that was very, very strange. But it’s, it’s…now I don’t 
see it anymore’. While at first it was an unusual situation, now 
she feels ‘at home over there’. The fact that for once she can 
‘look down’ at others is described by Linda as playing a role in 
her feeling at home, as if her gaze’s direction makes her closer to 
the members of the association.
This sense of familiarity with shorter people is expressed also 
by Luisa when she says that she ‘kind of connected’ with a girl at 
school because—even if this girl was shorter than she was—they 
were ‘both small’. Similarly, Jennifer says that being with people 
of the same height ‘feels nice for some reason’. The fact that 
others are ‘looking down’ at her is an issue of inequality, she 
says. She contrasts this idea with her experience of being with 
people who are similar to her own height: ‘connecting to a short 
person is not, it’s just equal’. She also attributes the fact that 
some people who are taller than her believe that she is younger 
than she is, or do not take her seriously, to the direction of their 
gaze. Jennifer says that looking down is ‘offensive’ and she likes 
being with shorter people because she feels ‘more powerful’.
In these accounts, the direction of one’s gaze is described as 
doing something to participants, whereas Frank describes himself 
as doing something with it. He shares the view of some of the 
other interviewees that taller people have ‘a natural preponder-
ance’ because they ‘look over’ shorter people. Taller persons have 
a sense of control, Frank argues, and explains: ‘in Dutch you say 
‘overwicht’. […] It’s like you have a natural balance in favour of 
you in social communication or interaction’. Thus, Frank holds 
that, since he is short, he holds an apparently weaker position, 
a disadvantage, but that he can transform it into a benefit. He 
claims that his ‘underdog’ position, his original ‘unfavourable 
position’ gives him freedom:
And then, that gives you an advantage. Because you can change 
this. Whereas, say, if you are in a favourable position, then you 
have to maintain that. Because I have the leverage even to give 
them the stereotypical feedback, the stereotypical image, and then 
turn it around when it suits me. So, it gives you an advantage as 
well.
While Frank portrays himself as enjoying the freedom to ‘play’ 
with stereotypesviii and other people’s expectations thanks to his 
height and to the way he looks at others and they look at him, 
Jack says that, for him, the gaze’s direction, whether one ‘looks 
up’ or ‘down’, does not have any special meanings. Jack instead 
focuses on being able to see. When he goes to concerts, he says, 
he makes plans beforehand, in order to get the best visual posi-
tion. Situations in which participants must make adjustments to 
interact with objects is also a recurring point in all interviewees’ 
narratives. These adjustments are made, for instance, when 
reaching for high shelves, driving a car or seeking clothes that 
fit. Jack describes his experience at the supermarket:
When I’m in a supermarket, and there is the funny thing, you have 
those cooler shelves with the doors, the cooler office, the refrigera-
tors, the big ones, mostly the top things, like butter or something, 
I don’t know. I cannot get there because it’s too high for me, and I 
have to get up like, like, like on a step. And then people see me like 
this tiny guy reaching out the highest stuff in the supermarket. I don’t 
have an issue with that because I think it’s funny so I’m happy that 
people think it’s funny too.
This narration is in line with Jack’s overall positive account. 
He stresses that being short is a reason for pride for him. While 
recounting several situations in which he looks ‘funny’ because 
of the way he interacts with objects, he portrays himself as 
having ‘the little brother type of personality’. He claims that 
being short is something that makes people see him as ‘friendly’ 
and ‘nice’, and he easily gains sympathy from others who 
somehow are inclined, he says, to ‘protect’ him. In other words, 
Jack describes his bodily interactions with others and objects as 
having an impact on how he is perceived—on how his person-
ality is perceived.
From the perspective of the embodied self as being-in-the-
world, things—such as tall refrigerators or high shelves—appear 
to the individual depending on what one wants to do, but certain 
shelves that are placed high on the wall will also stand out as 
insurmountable depending on their place on the wall in relation 
to one’s lived body, and in relation to whether there are steps 
available and whether the situation is experienced as comfort-
able enough to climb up and reach the ‘highest stuff ’. In this 
way, the perspective of the embodied self as being-in-the-world 
allows us to hold together materiality, sociality and affect in the 
analysis. There is also a temporal dimension: how one perceives 
present situations can be shaped by past experiences, such as not 
reaching things, and past interaction with others.45 In contrast to 
Jack’s narration, Linda tells of her experiences of not reaching 
things while doing gymnastics:
Well, I, to be honest, I hate sports. And, and I used to… I didn’t 
like gymnastics in school, either. I hated it. But because they had to 
change everything for me. I mean, if we had to do something, it was 
too high for me so, so they had to make it smaller and everything. So, 
and, well, I didn’t like it.
These accounts focus on basic relational becoming of bodily 
selves where singular, lived bodies are continuously shaped and 
come to be in exchanges between bodies (i.e., the intercorpore-
ality of the embodied self) and on how things such as high shelves 
or machines are perceived as impossible to reach, as hindrances 
or as challenges that can be overcome. Interviewees describe 
viii Frank associates being tall with what he defines as the common 
understanding of success. Therefore, according to him, being 
short, and ‘looking up’ represents an advantage in so far as it 
allows him to ‘play’ with these stereotypes.
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not only height as such, but height in relation to other specific 
things and situations as at times inhibiting and at other times 
enabling them, and as coshaping what they could be and do, 
and their attitudes towards the world. This is not to be under-
stood in a deterministic sense, as, for instance, the same inter-
actions assume a variety of meanings in participants’ narration. 
Each interviewee describes how these situations and interactions 
play a role in coshaping her or his meaning of height and conse-
quently of their ‘I can’. According to our framework of anal-
ysis, we read such coshaping as influenced by each interviewed 
individual’s perceptions of the world, others, themselves, their 
specific situations as embodied women and men, immersed in 
the sociocultural situation in which the interaction takes place. 
Once again, height assumes a meaning that transcends the rele-
vance of height in centimetres, and that is open to the ways indi-
viduals envisage themselves and interact with others and things.
height is gendered
The third and final theme centred on interviewees’ narrations of 
gendered beliefs and norms, in relation to height. On a number 
of occasions, interviewees explicitly suggest a relation between 
masculinity and tallness and between femininity and being 
‘petite’. Jennifer claims that for her brother, who is 173 cm, it is 
a problem to always be the shortest among his friends because 
‘it’s more masculine, I guess, for a guy to be taller than a girl’. In 
the same way, being tall is masculine for a girl because, she says, 
a really tall friend of her looks masculine. Masculinity is further 
described via terms such as ‘control’ and ‘protection’. Frank 
recounts that he did not feel in control in intimate moments 
with his previous girlfriend, who was taller than him. At first, her 
stature was not a problem. Only after a while, he did realise that 
he did not like to have sex with her because ‘it did not feel right’:
I found it difficult to have a sense of control. And it is not that sex for 
me is about control, or power, or something. But, it is… yeah… you 
have to play with this…with this…[pause]… with this… power… 
Yeah, Shit. How should I explain this? You know what I mean? Sex 
is not about power, but, in a way, it is also about submission, some-
times. It can be. And it can be both ways. But it did not feel equal. We 
could not shift equally in both those ways.
Frank’s narrative consolidates the dualism between two oppo-
site gender identities: men are supposed to be tall and have a 
sense of control, while women are supposed to be short and 
(more) submissive. This theme recurred with all interviewees: 
while men say that they prefer their female partner to be the same 
height or shorter than them, interviewed women say that they do 
not find short men attractive. Hannie holds that she would not 
date a short guy. She defines tall men as ‘more manly’ because, 
she says, she never saw the short boy who was in college with her 
‘as a potential [boyfriend]’. Sophia states that she prefers a taller 
man because she feels ‘safer’ and ‘more protected’. She also says 
that it is a ‘natural feeling’: men want to ‘protect’ their women 
and their families. Similarly, David says that with a taller girl-
friend he sometimes ‘doubt[s]’ his masculinity because he likes 
the idea of being stronger than her and being able to protect her, 
but also because in intimate moments it is easier and more prac-
tical if there is not too much difference in height, or if he is taller.
Participants also describe how they negotiate these beliefs and 
norms. Milly, for example, holds that sometimes it is a disadvan-
tage to be a short woman, while sometimes it is an advantage. 
She dislikes when others underestimate her, assuming that she 
is a kindergarten or primary school teacher, namely, what she 
defines as one of the ‘standard women jobs’. At the same time, 
being aware of the image that others have of her (as ‘sweet’ and 
‘cute’—this is also how short women are portrayed in all the 
interviews) is something she can turn in her favour: sometimes 
she can ‘use’ it to get what she wants. Linda, instead, states that, 
even if she does not like to be short, it is not as bad as other 
bodily marks. She tells that her colleagues at work call her ‘tiny 
Linda’, not to mistake her with another (taller) Linda. And this is 
not something that bothers her because:
I think it would be worst if they would say ‘fat Linda’. I mean, I am 
also fat, but I rather have them tell me that I am small than that I am 
fat. So… 
Even though she describes short stature as something negative, 
she portrays being fat as somehow worse—as if those aspects 
that she narrates as perceived limitations of short stature were 
not as problematic as the social norms about fat bodies. Through 
this narration, Linda creates a hierarchy of values, and in related 
ways Frank claims that he worries more about having poor 
eyesight than being short, and Hannie says that if she were ever 
bullied it would have been because she was a ‘nerd’, and not for 
her height. These narrations highlight an ongoing negotiation 
of norms and beliefs, which takes different shapes in different 
contexts.
However, this last theme also shows how gendered assump-
tions and norms about bodies are sometimes taken for granted 
and lived rather than reflected on, and sometimes negotiated, 
and how in both cases they can help shape interviewees’ ways 
of thinking about height when explicitly asked about it. Again, 
we make use of a phenomenological notion in order to shed 
light on how some of these gendered norms can be deeply 
rooted in one’s habitual way of being-in-the-world. Drawing on 
Merleau-Ponty’s discussion of how objects and skills, through 
habituation and repeated motor activity, can come to be incor-
porated into one’s lived body, more recent phenomenological 
literature has suggested that it makes sense to think of certain 
types of shared cultural patterns of understanding—including 
gendered behaviour and norms about bodies—as habitually 
incorporated in this fashion. Individuals may appropriate some 
such behaviours and norms through repeated actions, over 
time, and through continual practice, such patterns of behav-
iour can make their way into the pre-reflective bodily layer 
of our being and congeal as more or less fixed socially shared 
habits; they become incorporated into one’s lived bodily exist-
ence.41 42 And one of the analytic points of this understanding 
of gendered patterns of behaviour is that it can help explain the 
elusiveness of gendered assumptions and norms that primarily 
are at work in the taken-for-granted domain of bodily exist-
ence.41 42
As incorporated, such assumptions and norms ‘belong to that 
from which we make sense of the world, act and interact, and 
thus rarely present themselves as that to which we direct our 
attention’ (Malmqvist and Zeiler, p. 144),42 and only if some-
thing happens—that make us excorporate these previously lived 
assumptions and norms—we can question them. Further, such 
excorporation is by no means easy, and the assumptions and 
norms might, at a later stage, be reincorporated.42
The phenomenon of more or less taken-for-granted (and 
because of this elusive) gendered norms can help explicate 
participant’s narrations about partner preferences. Frank illus-
trates this well when he narrates how he just could not question 
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gendered norms when it came to his partner.ix As seen above, 
Frank had a taller girlfriend and at first this was not a problem 
for him; he even described a certain sense of satisfaction in 
showing him and his girlfriend as a couple to others. After a 
while, however, he realised that the idea that he could not be ‘in 
control’ was so deeply rooted in him that he finally split up with 
her. Even if he described a satisfaction at the public display of 
them as a couple, and even if he explained that he tried to ques-
tion norms about masculinity, control and height, he could only 
do it up to a certain point.
The ConTribuTion of soCiophenomenology of The 
body To disCussions on hgh
Elsewhere, it has been argued that phenomenology can contribute 
to bioethics through its examination of how certain norms about 
bodies can become taken for granted and help motivate surgery 
intended to make bodies conform to specific norms, and the 
examination of what this means for individuals undergoing a 
particular treatment.59–61 Such research invites readers to criti-
cally think through assumptions and norms that they—we—at 
times might ‘just’ live. Phenomenology also offers an alternative 
perspective in the sense that it attends to existential and lived 
dimensions of bioethical issues.62 63 The analysis offered so far 
does both: it spells out lived experiences and (gendered) norms 
about height and it provides an alternative understanding of 
height that, as we will argue in this section, can enrich bioethical 
discussions.x
To sum up, our analysis has shown how participants make 
sense of height in three main ways. First, height is narrated as an 
active engagement in space. Interviewees talk only occasionally 
of their height as a bodily characteristic that they observe as an 
object, external to them, from a distance. Instead, they focus on 
the ways they move in space, do things and relate to others. They 
narrate height as an activity. Height is described not in numbers 
but in action, not merely as a physical or aesthetic characteristic 
of their bodies but as an engagement with the world or as we 
have called it: ‘heighting’. Second, height helps shape partici-
pants’ habituated bodily agency, in diverse ways, and bodily 
agency is also shaped in relations with others and things: some 
places come to be perceived as inhospitable and some people 
as familiar, in the same way high shelves might be perceived as 
unreachable. Such a variety of meaning-makings is shaped and 
understood in relation to one’s embodiment as a person that 
identifies with a specific gender, cultural community, certain 
abilities and so on. Third, perception and narrated lived expe-
rience of height is closely related to gender norms and beliefs. 
Interviewees narrate assumptions and norms about gendered 
bodies as more or less self-evident, and taken for granted, and 
draw on such taken-for-granted assumptions and norms when 
describing themselves as short women or short men.
This analysis helps us understand how height can be lived, and 
it attends to assumptions and norms about height— not merely 
ix Elusive norms are norms that are taken-for-granted in many 
everyday situations, and thus might be difficult to express. Such 
norms can nevertheless help shape behaviour. For discussions of 
elusive norms, phenomenology and bioethics, see, for example, 
Malmqvist (2014). 68
x Our interviews might be analysed and discussed from different 
angles. For instance, Lakoff and Johnson (1999)69 talk about 
high/low and up/down metaphors. However, they do so with a 
very different focus. While they aim at exploring the nature of 
embodied cognition, our approach instead relies on embodiment 
as understood by Merleau-Ponty.
as potential problems—but as shaped in and shaping encounters 
with others, in different ways. This, we will now argue, is also 
a contribution to biomedical and bioethical discussions on hGH 
treatment: this sociophenomenological analysis of short stature 
as lived can be used to underline the need to move beyond a 
one-sided focus on potential problems that short stature might 
entail, without glossing over interviewees’ narrations and 
accounts of situations that they do describe as painful.
The sociophenomenological analysis demonstrates the short-
comings of seeing short stature through the lenses of the prob-
lem-oriented approach and brings forth how the experience of 
height varies and unfolds in and through lived encounters. To 
recognise these aspects of height as a lived phenomenon adds 
nuances that are important also for ethical discussions, and this 
understanding of height is different from the one where objec-
tive height and quantitative measure in centimetres become 
central. As shown above, height in centimetres was mentioned 
only briefly by interviewees, who do not narrate it as having 
fundamental relevance for their daily lives. They rather focus 
primarily on their embodied ways of being shorter than average, 
which assume different meanings in interactions with others and 
objects, and the overall appreciation of one’s body. We suggest 
that this understanding of height, at the level of lived experi-
ence—which still acknowledges the physical body of a certain 
height, but through the first-person experience—should be the 
starting point for discussions on hGH treatment in children with 
ISS.
Taking such a perspective seriously would require moving 
away from the idea of objective height as central to discussions 
of psychosocial disadvantages or problems, and of such disad-
vantages and problems as possible results of short stature, or 
preventable by increasing height—that is, moving away from 
ideas that were central to what we labelled a problem-oriented 
approach to hGH treatment. While we acknowledge that some 
individuals can experience short stature as troubling (and as trou-
bling in some situations more so than others), we are concerned 
that explicitly focusing on possible disadvantages in discussions 
of ISS risks imposing a partial sensitivity to the issues at stake. 
Indeed, such framing might send the message that some psycho-
social disadvantages are to be expected because of the child’s 
bodily deviation from the average, thereby reinforcing negative 
assumptions about short stature.xi Let us illustrate this point with 
an example.
The short-stature-specific quality of life measurement 
(QoLISSY) is a questionnaire developed to be used in different 
languages and countries. It has already been tested in several 
European countries (including the Netherlands)64 and the USA.65 
The QoLISSY aims to assess possible effects of hGH treatment 
and psychological interventions in children diagnosed with short 
stature.25 This instrument has been designed for a health-re-
ferral population (children and adolescents already referred to 
an endocrinology clinic) to be used in research and clinics,25xii 
for both children who are undergoing hGH treatment and those 
xi For a discussion of the role of measuring tools and charts in 
creating the way we currently assess pubertal development and 
sexual maturation, see Roberts (2016)70 .
xii QoLISSY is used for both GHD and ISS, despite their differ-
ence in diagnostic and treatment rationale worldwide. While 
children with GHD have a dysfunction of the pituitary gland, 
children with ISS do not. Since GHD children might have 
non-height-related health problems (e.g., metabolic functioning 
and bones growth), hGH treatment is justified for GHD because 
it is not only limited to height increase.
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who are not.xiii The QoLISSY consists of Likert-scaled framed 
statements, to be asked to parents and to short children/adoles-
cents (8–18 years old). Below we list three of these statements 
(the first two to be addressed to the children and last one to the 
parents):
 ► ‘Because of my height, I have more trouble reaching things 
than others my age.’
 ► ‘I have to look up at others my age when I talk to them.’
 ► ‘My child worries about what people might say about his/her 
height in the future.’
According to the QoLISSY, the higher the answers’ scores, the 
lower the child’s quality of life (they can choose their answer 
among the limited nuances offered by replying between 1 corre-
sponding to ‘never’ and 5 ‘always’). However, this tool frames 
the assessment of quality of life of children with short stature in 
a way that cannot recognise or appreciate the different meanings 
that emerged from our interviews’ analysis. Let us explain how. 
In the first question, the use of the word ‘trouble’ refers to some-
thing negative, but it is not clear in what ways and to what extent 
children are affected by these ‘troubles’ in their daily lives. In the 
interviews, most of the participants refer to some kind of limita-
tions in their relations to objects. These limitations are most of 
the time not described as problematic. Participants say that they 
have to make a number of considerations before doing certain 
things, and while these limitations sometimes are described as 
troubling, this is not always the case. Therefore, assuming that an 
affirmative answer to the first statement is inversely proportional 
to the quality of life of this child and adult-to-be is misleading. 
Second, ‘looking up’ is interpreted in the QoLISSY as negative. 
We have seen above, however, that while this sometimes is the 
case, there is more to it: at times, looking up was described by 
our interviewees as positive or as neutral. Third, the statement 
uses the word ‘worries’ while sometimes people might simply 
wonder about what other people would say of them. This does 
not mean that people have an overall negative appraisal of them-
selves (see above the case of David who, looking at his picture, 
wonders about other people’s opinions, yet often describes his 
bodily stature in positive terms).
The QoLISSY is an illustrative example of how common under-
standing of height as something negative (because of presumed 
potential social discrimination) risks limiting the interpretation 
of short people’s lived experience and overestimating the role of 
hGH treatment.xiv It exemplifies the problem-oriented approach 
to justifying hGH treatment for children with ISS: the focus is on 
potential problems of short stature, not on different meanings 
and experiences of it, and quantitative measurement becomes 
central. The sociophenomenological analysis, by contrast, calls 
xiii The lack of distinction between children who are undergoing 
hGH treatment and those who are not is problematic because 
technologies might shape their experiences differently.71 
xiv Other ethical considerations should be made about the 
QoLISSY questionnaire. Among these, since the questionnaire 
is to be provided to children who have been referred to clinics, 
factors other than short stature should be taken into consid-
eration. Given that one’s meaning-making is shaped intersub-
jectively, and in continuous exchange with others and things, 
a comprehensive ethical evaluation should also consider, for 
instance, the way doctors and families explained to them their 
need for further medical examinations. Moreover, QoLISSY is 
used with both children who are taking the treatment and those 
who are not, but it is likely they might have different lived expe-
riences and, consequently, meaning-makings of short stature 
(because of the administration of treatment itself and the way it 
is justified to them, and with them).
for more open discussions of how short stature can be experi-
enced. It can be understood as underlining the value and need to 
leave room for analyses of the lived experience of short stature. 
Given the recent debate in biomedical and bioethical literature 
on the need to restrict the use of hGH for ISS, an approach 
centred on lived experiences allows nuanced discussions that 
consider the child’s meaning-making within her or his sociocul-
tural environment.
ConClusion
The prescription of hGH treatment for children with ISS is 
controversial because there is no proven relation between 
psychological and social problems and short stature. There is 
also a lack of evidence that hGH treatment might have posi-
tive outcomes for children’s well-being. Based on our inter-
views’ analysis, and the understanding of lived experiences of 
short stature that it portrays, we suggest a shift in perspective. 
Rather than following the problem-oriented approach that looks 
at short stature (understood in terms of objective height) as 
possible cause of psychosocial problems, we argue for the need 
to focus on the lived experiences of children who are shorter 
than average and be open to the richness of meanings that they 
can give to their height. Making a phenomenological analysis of 
lived experience allows for recognition of the role of embodi-
ment for subjectivity; how the lived body is and sets the condi-
tions of possibility of perception and action. It allows, as seen, 
to show how height helps shape participants’ bodily agency, in 
diverse ways, and bodily agency is also shaped in relations with 
others and things.
Based on our analysis, we suggest that the rationale for inter-
vention should not be the prevention of possible risks but the 
actual lived experience of the child. Besides psychological and 
medical tests, the lived experience of children should be inves-
tigated before making assessments for hGH treatment. Taking 
again the example of QoLISSY, since it is a multiple-choice ques-
tionnaire, we believe that it has some structural limitations on 
what it can grasp about lived experiences.xv While it might be 
useful to think of different formulations for the current ques-
tions, this would not address our main concern about the limi-
tations of QoLISSY to capture the nuances of living with short 
stature. This tool should instead be complemented with narrative 
approaches attentive of children’s lived experience. The ques-
tion should not be whether short stature in itself brings prob-
lems, but how the specific child might see and experience her 
or his height, given the sociocultural context in which he or she 
lives. This does not provide clear-cut answers, but it underlines 
the importance of looking at children’s well-being as something 
beyond their bodies in statistical comparisons with others. While 
individuals’ experiences are always affected by sociocultural 
meaning, the ways in which this happens might be multiform 
and we should pay attention at not limiting these meanings to 
common-sense assumptions.
We see three limitations of this study. First, because of the 
recruitment methods (especially the involvement of social 
network and snowball sampling), some of the participants know 
each other and have similar backgrounds. Most of them have 
higher education level. However, they are different ages and 
they live in different areas of the country. Second, since English 
xv See, for instance, what one of us has written on the limitations 
of a quality of life tool in oncology aftercare for the under-
standing of lived experiences, and how narratives can improve 
such assessment (see Slatman (2011)72.
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is not a native language for both the interviewer and the partic-
ipants, we are aware that some meanings might have been lost. 
However, all the participants are fluent in English and looked at 
ease during the conversation. Additionally, one of the authors 
is a native Dutch speaker. Third, participants were asked in the 
interviews how they experienced short stature in everyday life 
and could choose to talk about both present and past experi-
ences. The decision to let participants choose the experiences 
they wished to talk about was motivated by our focus on subjec-
tive meaning-making. For this reason, we did not make a sharp 
distinction between recollection of experiences that were recent 
and those that were more distant. Having said that, we acknowl-
edge that temporality matters in the sense that recollections of 
events that are recent can be more detailed (and that recollec-
tions always are selective, and that all narrated experiences, of 
course, are recollections).
We believe that further research is needed in the biomedical 
and bioethical debate of using hGH treatment. For instance, 
it is an open question whether it should be made a distinction 
between ISS and other conditions currently treated with hGH or 
not, such as Turner syndrome or small for gestational age. More-
over, more critical research should be done on how and why 
(gendered) norms about height are so deeply rooted and how 
they can affect children. Finally, there is need for further research 
that problematises biomedical and bioethical debates on ISS and 
other medical interventions that aim to modify children’s bodily 
marks that deviate from statistical norms, such as oestrogen 
treatments to reduce tall girls’ height, orthodontic braces and 
intersex conditions.
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